SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-042530
Filing Date
2010-08-06
Accepted
2010-08-06 07:02:52
Documents
5
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-12789_110q.htm 10-Q 970998
2 EX-3.1 a10-12789_1ex3d1.htm EX-3.1 79604
3 EX-31.1 a10-12789_1ex31d1d1.htm EX-31.1.1 11826
4 EX-31.2.1 a10-12789_1ex31d2d1.htm EX-31.2.1 11826
5 EX-32.1 a10-12789_1ex32d1.htm EX-32.1 7832
  Complete submission text file 0001104659-10-042530.txt   1083514
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 10996275
SIC: 2836 Biological Products, (No Diagnostic Substances)